Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Darren Wan-Teck Lim1, Dorothy Hui Lin Ng2, Jenny Guek-Hong Low2

  • 1École des sciences infirmières de l'Université Duke (Lim); Hôpital général de Singapour (Ng); Programme des maladies infectieuses émergentes (Low); École des sciences infirmières de l'Université Duke, Maladies infectieuses (Low), Hôpital général de Singapour, Singapour. dmolwt@nccs.com.sg.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|October 19, 2021
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic Count and Local Ablative Therapy Influence Survival Outcomes in Oligometastatic Nasopharyngeal Carcinoma Patients.

Head & neck·2026
Same author

Navigating the Future of Respiratory Infections: Key Insights From International Congress in Singapore, 17-20 September 2025.

Influenza and other respiratory viruses·2026
Same author

Development and Validation of Lung Cancer Risk Prediction Models in the Singapore Chinese Population.

Clinical lung cancer·2026
Same author

Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decade.

Translational oncology·2026
Same author

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

JCO global oncology·2026
Same author

Utility of various programmed death-ligand 1 (PD-L1) assays in predicting the clinical benefit of immune checkpoint inhibitors in PD-L1-expressing non-small-cell lung cancer patients: a systematic review.

Translational lung cancer research·2026